Vaxart, Inc. (VXRT)

Vaxart Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-82.47	-107.76	-70.47	-32.22	-18.65
Depreciation & Amortization	8.62	5.81	4.21	2.71	3.6
Share-Based Compensation	14.13	13.59	8.87	4.36	0.63
Other Operating Activities	-10.74	-6.41	-2.44	1.4	1.33
Operating Cash Flow	-70.45	-94.78	-59.83	-23.75	-13.09
Capital Expenditures	-1.75	-9.6	-5.16	-1.22	-0.85
Acquisitions	0	0	-4.83	0	0
Change in Investments	45.7	-10.81	-39.11	0	0
Investing Cash Flow	43.95	-20.42	-49.1	-1.22	-0.85
Share Issuance / Repurchase	15.61	17.46	125.8	137.66	19.76
Debt Issued / Paid	0	0	0	0	-3.8
Other Financing Activities	-0.37	-	-	0.65	-
Financing Cash Flow	15.24	17.46	125.8	138.31	15.96
Net Cash Flow	-11.26	-97.73	16.88	113.34	2.02
Free Cash Flow	-72.2	-104.38	-64.99	-24.97	-13.94
Free Cash Flow Margin	-978.51%	-97551.40%	-7285.76%	-617.15%	-141.35%
Free Cash Flow Per Share	-0.50	-0.82	-0.54	-0.28	-0.65

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).